Published in J Immunol on June 01, 1993
Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med (2005) 4.16
Autoreactivity in human IgG+ memory B cells. Immunity (2007) 3.71
Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood (2010) 3.52
Human immunoglobulin selection associated with class switch and possible tolerogenic origins for C delta class-switched B cells. J Clin Invest (2004) 2.21
Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci U S A (2008) 2.18
Autoreactive B cells in the marginal zone that express dual receptors. J Exp Med (2002) 2.16
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. J Clin Invest (2009) 2.11
Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J Exp Med (2003) 2.09
Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. J Clin Invest (2004) 1.94
Bruton's tyrosine kinase is essential for human B cell tolerance. J Exp Med (2004) 1.94
Checkpoints in lymphocyte development and autoimmune disease. Nat Immunol (2009) 1.84
IRAK-4- and MyD88-dependent pathways are essential for the removal of developing autoreactive B cells in humans. Immunity (2008) 1.83
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation. Mol Med (2008) 1.82
The evolution of human anti-double-stranded DNA autoantibodies. Proc Natl Acad Sci U S A (2005) 1.53
Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice. J Immunol (2007) 1.36
Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J Exp Med (1999) 1.36
Light chain editing in kappa-deficient animals: a potential mechanism of B cell tolerance. J Exp Med (1994) 1.29
Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. J Exp Med (2010) 1.29
Anti-DNA B cells in MRL/lpr mice show altered differentiation and editing pattern. J Exp Med (2002) 1.28
Pathogenic profiles and molecular signatures of antinuclear autoantibodies rescued from NZM2410 lupus mice. J Exp Med (2004) 1.22
Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Infect Immun (1995) 1.21
Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells. J Exp Med (1995) 1.17
Human autoantibody recognition of DNA. Proc Natl Acad Sci U S A (1995) 1.17
A genetic lesion that arrests plasma cell homing to the bone marrow. Proc Natl Acad Sci U S A (2003) 1.16
Structural basis for autoantibody recognition of phosphatidylserine-beta 2 glycoprotein I and apoptotic cells. Proc Natl Acad Sci U S A (2001) 1.15
The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease. Immunol Rev (2003) 1.13
Repertoire cloning of lupus anti-DNA autoantibodies. J Clin Invest (1996) 1.11
Lupus-specific antibodies reveal an altered pattern of somatic mutation. J Clin Invest (1997) 1.09
Structure of the VH and VL segments of monoreactive and polyreactive IgA autoantibodies to DNA in patients with systemic lupus erythematosus. J Immunol (1994) 1.08
TLR9 promotes tolerance by restricting survival of anergic anti-DNA B cells, yet is also required for their activation. J Immunol (2013) 1.07
Structure-function analysis of a lupus anti-DNA autoantibody: central role of the heavy chain complementarity-determining region 3 Arg in binding of double- and single-stranded DNA. Eur J Immunol (2000) 1.06
Editing anti-DNA B cells by Vlambdax. J Exp Med (2004) 1.06
Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy. J Clin Invest (2012) 1.06
Experimental expression in mice and spontaneous expression in human SLE of polyomavirus T-antigen. A molecular basis for induction of antibodies to DNA and eukaryotic transcription factors. J Clin Invest (1997) 1.06
Random mutagenesis of two complementarity determining region amino acids yields an unexpectedly high frequency of antibodies with increased affinity for both cognate antigen and autoantigen. J Exp Med (1995) 1.05
Consequences of receptor editing at the lambda locus: multireactivity and light chain secretion. Proc Natl Acad Sci U S A (2006) 1.03
Light chain editing generates polyreactive antibodies in chronic graft-versus-host reaction. J Exp Med (2006) 1.02
B cell receptor editing in tolerance and autoimmunity. Ann N Y Acad Sci (2011) 1.01
Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity. Semin Immunopathol (2013) 0.99
Immunoglobulin heavy chain diversity in Pteropid bats: evidence for a diverse and highly specific antigen binding repertoire. Immunogenetics (2010) 0.99
Divergent members of a single autoreactive B cell clone retain specificity for apoptotic blebs. Mol Immunol (2006) 0.93
The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin. Arthritis Res Ther (2004) 0.92
Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells. Mol Med (2008) 0.92
Ligand recognition by murine anti-DNA autoantibodies. II. Genetic analysis and pathogenicity. J Clin Invest (1996) 0.91
Alternative mechanisms of receptor editing in autoreactive B cells. Proc Natl Acad Sci U S A (2011) 0.91
Linking complement and anti-dsDNA antibodies in the pathogenesis of systemic lupus erythematosus. Immunol Res (2013) 0.90
Editing and escape from editing in anti-DNA B cells. Proc Natl Acad Sci U S A (2008) 0.89
Serological and genetic characterization of a human monoclonal immunoglobulin G anti-DNA idiotype. J Clin Invest (1994) 0.89
Checkpoints that control B cell development. J Clin Invest (2015) 0.89
Anti-DNA antibodies - quintessential biomarkers of SLE. Nat Rev Rheumatol (2015) 0.88
Immunological aspects in chronic lymphocytic leukemia (CLL) development. Ann Hematol (2012) 0.88
Anti-nuclear antibody reactivity in lupus may be partly hard-wired into the primary B-cell repertoire. Mol Immunol (2009) 0.87
Identification of a lipid peroxidation product as the source of oxidation-specific epitopes recognized by anti-DNA autoantibodies. J Biol Chem (2010) 0.85
Contribution of V(H) replacement products in mouse antibody repertoire. PLoS One (2013) 0.85
The restricted DH gene reading frame usage in the expressed human antibody repertoire is selected based upon its amino acid content. J Immunol (2013) 0.84
Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity. Arthritis Res Ther (2005) 0.83
Violation of an evolutionarily conserved immunoglobulin diversity gene sequence preference promotes production of dsDNA-specific IgG antibodies. PLoS One (2015) 0.83
Selection of individual VH genes occurs at the pro-B to pre-B cell transition. J Immunol (2011) 0.82
Analysis of immunoglobulin variable region genes of a human IgM anti-myeloperoxidase antibody derived from a patient with vasculitis. Immunology (1996) 0.80
Autoantibodies: Focus on anti-DNA antibodies. Self Nonself (2011) 0.79
Antibodies that bind complex glycosaminoglycans accumulate in the Golgi. Proc Natl Acad Sci U S A (2013) 0.79
Activation-induced deaminase contributes to the antibody-independent role of B cells in the development of autoimmunity. Autoimmunity (2012) 0.78
TLR7 influences germinal center selection in murine SLE. PLoS One (2015) 0.78
Role of Structure-Based Changes due to Somatic Mutation in Highly Homologous DNA-Binding and DNA-Hydrolyzing Autoantibodies Exemplified by A23P Substitution in the VH Domain. Autoimmune Dis (2012) 0.78
Phylogenetic conservation of the 3' cryptic recombination signal sequence (3'cRSS) in the VH genes of jawed vertebrates. Front Immunol (2012) 0.78
Molecular hallmarks of anti-chromatin antibodies associated with the lupus susceptibility locus, Sle1. Mol Immunol (2009) 0.78
Predominant role for activation-induced cytidine deaminase in generating IgG anti-nucleosomal antibodies of murine SLE. J Autoimmun (2015) 0.77
The role of rearrangement at the second Ig heavy chain locus in maintaining B cell tolerance to DNA. J Immunol (2008) 0.77
Light chain editors of anti-DNA receptors in human B cells. J Exp Med (2014) 0.77
Specific recognition of a dsDNA sequence motif by an immunoglobulin VH homodimer. Protein Sci (2004) 0.75
Functional Versatility of AGY Serine Codons in Immunoglobulin Variable Region Genes. Front Immunol (2016) 0.75
CDR3 regions in the preimmune VH B cell repertoire of lpr mice. Clin Exp Immunol (1995) 0.75
Mapping an epitope in EBNA-1 that is recognized by monoclonal antibodies to EBNA-1 that cross-react with dsDNA. Immun Inflamm Dis (2016) 0.75
Expansion of B-1a Cells with Germline Heavy Chain Sequence in Lupus Mice. Front Immunol (2016) 0.75
Alterations in B cell development, CDR-H3 repertoire and dsDNA-binding antibody production among C57BL/6 ΔD-iD mice congenic for the lupus susceptibility loci sle1, sle2 or sle3. Autoimmunity (2017) 0.75
Structural models of antibody variable fragments: a method for investigating binding mechanisms. J Comput Aided Mol Des (1998) 0.75
Phenotyping of autoreactive B cells with labeled nucleosomes in 56R transgenic mice. Sci Rep (2017) 0.75
Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A (1982) 11.15
Effect of internal viral sequences on the utility of retroviral vectors. J Virol (1987) 6.06
Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1984) 5.49
Receptor editing: an approach by autoreactive B cells to escape tolerance. J Exp Med (1993) 5.49
Structure of the cro repressor from bacteriophage lambda and its interaction with DNA. Nature (1981) 5.24
Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature (1981) 4.78
Gene expression in mice after high efficiency retroviral-mediated gene transfer. Science (1985) 4.77
Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J Exp Med (1990) 4.46
Genetics of the antibody response to dextran in mice. Science (1972) 4.37
Localization of the human alpha-globin structural gene to chromosome 16 in somatic cell hybrids by molecular hybridization assay. Cell (1977) 4.34
Multiple sequence alignment. J Mol Biol (1986) 4.27
Identification and nucleotide sequence of a diversity DNA segment (D) of immunoglobulin heavy-chain genes. Nature (1981) 4.19
Prospects for human gene therapy. Science (1984) 3.93
Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia. Proc Natl Acad Sci U S A (1983) 3.90
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science (1983) 3.82
Translocation of an immunoglobulin kappa locus to a region 3' of an unrearranged c-myc oncogene enhances c-myc transcription. Proc Natl Acad Sci U S A (1983) 3.75
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci U S A (1986) 3.68
Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science (1984) 3.64
DNA-binding proteins. Science (1983) 3.56
The molecular basis of DNA-protein recognition inferred from the structure of cro repressor. Nature (1982) 3.56
Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin. J Exp Med (1985) 3.54
Transcriptional activation of an unrearranged and untranslocated c-myc oncogene by translocation of a C lambda locus in Burkitt. Proc Natl Acad Sci U S A (1983) 3.53
Transcriptional activation of the translocated c-myc oncogene in burkitt lymphoma. Proc Natl Acad Sci U S A (1983) 3.46
Assignment of the genes for human lambda immunoglobulin chains to chromosome 22. Nature (1981) 3.43
Differential expression of the normal and of the translocated human c-myc oncogenes in B cells. Proc Natl Acad Sci U S A (1983) 3.43
Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science (1983) 3.40
Transcription of mouse kappa chain genes: implications for allelic exclusion. Proc Natl Acad Sci U S A (1980) 3.38
Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature (1991) 3.32
Translocation of immunoglobulin VH genes in Burkitt lymphoma. Proc Natl Acad Sci U S A (1982) 3.30
Recombination between an expressed immunoglobulin heavy-chain gene and a germline variable gene segment in a Ly 1+ B-cell lymphoma. Nature (1986) 3.24
pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J Virol (1994) 2.87
Rearrangement of genetic information may produce immunoglobulin diversity. Nature (1979) 2.84
Structural similarity in the DNA-binding domains of catabolite gene activator and cro repressor proteins. Proc Natl Acad Sci U S A (1982) 2.84
The regulation of initiation of mammalian protein synthesis. Prog Nucleic Acid Res Mol Biol (1981) 2.81
B lymphocytes may escape tolerance by revising their antigen receptors. J Exp Med (1993) 2.78
A mouse model for beta-thalassemia. Cell (1983) 2.70
Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer (2006) 2.68
Isolation and partial characterization of reticulocyte factors M1 and M2. J Biol Chem (1970) 2.59
Immunoglobulin heavy chain gene replacement: a mechanism of receptor editing. Immunity (1995) 2.56
Regional gene assignment of human porphobilinogen deaminase and esterase A4 to chromosome 11q23 leads to 11qter. Proc Natl Acad Sci U S A (1981) 2.50
Human gene therapy. Annu Rev Biochem (1993) 2.49
Genetic and structural evidence for antigen selection of anti-DNA antibodies. Annu Rev Immunol (1994) 2.45
DNA between variable and joining gene segments of immunoglobulin kappa light chain is frequently retained in cells that rearrange the kappa locus. Proc Natl Acad Sci U S A (1982) 2.36
Genetic control of antibody variable regions. Cold Spring Harb Symp Quant Biol (1977) 2.35
Gene for alpha-chain of human T-cell receptor: location on chromosome 14 region involved in T-cell neoplasms. Science (1985) 2.33
Continuous subcutaenous administration of deferoxamine in patients with iron overload. N Engl J Med (1977) 2.31
The joining of V and J gene segments creates antibody diversity. Nature (1980) 2.28
Factors for the initiation of haemoglobin synthesis by rabbit reticulocyte ribosomes. Nature (1970) 2.27
Detection of receptor-specific murine leukemia virus binding to cells by immunofluorescence analysis. J Virol (1992) 2.25
Cell-free hemoglobin synthesis. II. Characteristics of the transfer ribonucleic acid-dependent assay system. J Biol Chem (1970) 2.24
Immunochemical analysis of the cross-reacting idiotypes of mouse myeloma proteins with anti-dextran activity and normal anti-dextran antibody. Proc Natl Acad Sci U S A (1973) 2.21
Covalent structure of a group-specific protease from rat small intestine. Appendix: crystallographic data for a group specific protease from rat intestine. Biochemistry (1978) 2.17
Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins. J Virol (1993) 2.12
Identification of a subdomain in the Moloney murine leukemia virus envelope protein involved in receptor binding. J Virol (1996) 2.12
Replication and expression of thymidine kinase and human globin genes microinjected into mouse fibroblasts. Proc Natl Acad Sci U S A (1980) 2.10
Structure of the DNA-binding region of lac repressor inferred from its homology with cro repressor. Proc Natl Acad Sci U S A (1982) 2.09
Cloning and characterization of DNA sequences surrounding the human gamma-, delta-, and beta-globin genes. Proc Natl Acad Sci U S A (1980) 2.04
Translation of exogenous messenger RNA for hemoglobin on reticulocyte and liver ribosomes. Proc Natl Acad Sci U S A (1971) 2.03
Genes for immunoglobulin heavy chain and serum prealbumin protein are linked in mouse. Nature (1975) 2.01
Revising B cell receptors. J Exp Med (2000) 1.96
Ig H and L chain contributions to autoimmune specificities. J Immunol (1991) 1.96
Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther (1994) 1.95
Light chain replacement: a new model for antibody gene rearrangement. J Exp Med (1995) 1.90
Cloning and sequencing of a c-myc oncogene in a Burkitt's lymphoma cell line that is translocated to a germ line alpha switch region. Mol Cell Biol (1985) 1.90
Editors and editing of anti-DNA receptors. Immunity (2001) 1.90
The site and stage of anti-DNA B-cell deletion. Nature (1995) 1.87
Infection efficiency of T lymphocytes with amphotropic retroviral vectors is cell cycle dependent. J Virol (1989) 1.86
Multiplicity of germline genes specifying a group of related mouse kappa chains with implications for the generation of immunoglobulin diversity. Nature (1979) 1.85
Kinetic studies on Cro repressor-operator DNA interaction. J Mol Biol (1987) 1.85
Purification and physical properties of homogeneous initiation factor MP from rabbit reticulocytes. J Biol Chem (1975) 1.83
Seeding of intravascular stents with genetically engineered endothelial cells. Circulation (1989) 1.82
Binding kinetics of ecotropic (Moloney) murine leukemia retrovirus with NIH 3T3 cells. J Virol (1995) 1.82
Editing disease-associated autoantibodies. Immunity (1997) 1.81
Many gene-regulatory proteins appear to have a similar alpha-helical fold that binds DNA and evolved from a common precursor. J Mol Evol (1983) 1.80
A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia. Proc Natl Acad Sci U S A (1984) 1.79
Mouse lambda-chain sequences. Proc Natl Acad Sci U S A (1973) 1.78
Translation of rabbit haemoglobin messenger RNA by thalassaemic and non-thalassaemic ribosomes. Nat New Biol (1971) 1.75
Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias. Science (1986) 1.75
Isolation and translation of hemoglobin messenger RNA from thalassemia, sickle cell anemia, and normal human reticulocytes. J Clin Invest (1971) 1.74
Locus of the alpha-chain of the T-cell receptor is split by chromosome translocation in T-cell leukemias. Science (1985) 1.71
Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J Virol (1997) 1.70
Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry. J Virol (1994) 1.69
Inhibition of protein synthesis in rabbit reticulocyte lysates by double-stranded RNA and oxidized glutathione: indirect mode of action on polypeptide chain initiation. Proc Natl Acad Sci U S A (1975) 1.68
How immunoglobulin V kappa genes rearrange. J Immunol (1987) 1.68
Genetics of mouse antibodies. I. Linkage of the dextran response locus, VH-DEX, to allotype. Eur J Immunol (1975) 1.68
Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy. Nucleic Acids Res (1992) 1.66
Human gene therapy protocols: RAC review. Science (1995) 1.64
Nucleotide sequence of the dmsABC operon encoding the anaerobic dimethylsulphoxide reductase of Escherichia coli. Mol Microbiol (1988) 1.63
Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J Exp Med (1997) 1.63
Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene-transfer: implications for human gene therapy. J Virol Methods (1989) 1.63
Deletion and editing of B cells that express antibodies to DNA. J Immunol (1994) 1.62
Prospects for in utero human gene therapy. Science (1999) 1.61
Structural and functional homology of parvovirus and papovavirus polypeptides. J Gen Virol (1987) 1.59
Retracted Heparin-binding growth factor 1 induces the formation of organoid neovascular structures in vivo. Proc Natl Acad Sci U S A (1989) 1.59